Selected article for: "case report and interstitial pneumonia"
Author: Carannante, Novella; Fiorentino, Giuseppe; Corcione, Antonio; Di Sarno, Raffaele; Spatarella, Micaela; Maturo, Nicola; Fragranza, Fiorentino; Di Micco, Pierpaolo
Title: Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report
  • Cord-id: y4rovbpy
  • Document date: 2020_7_16
    • ID: y4rovbpy
    Snippet: Polyclonal preparation of IgM as an adjuvant therapy has been reported as a relevant immunomodulant therapy in several infectious diseases, exhibiting, in most cases, improvement of the clinical course. No drug has demonstrated therapeutic efficacy for COVID-19. Immunomodulatory treatment with hydroxychloroquine and biologics as tocilizumab, in fact, has not proven to show satisfactory results in several reports. We therefore treated a selected patient with interstitial multifocal pneumonia, pos
    Document: Polyclonal preparation of IgM as an adjuvant therapy has been reported as a relevant immunomodulant therapy in several infectious diseases, exhibiting, in most cases, improvement of the clinical course. No drug has demonstrated therapeutic efficacy for COVID-19. Immunomodulatory treatment with hydroxychloroquine and biologics as tocilizumab, in fact, has not proven to show satisfactory results in several reports. We therefore treated a selected patient with interstitial multifocal pneumonia, positive to COVID-19, with polyclonal preparation of immunoglobulins as an adjuvant therapy, obtaining in few days clinical remission and improvements in radiological findings. Based on this case report, we suggest that clinical trials are conducted to test the efficacy and safety of polyclonal immunoglobulins for adjunctive therapy of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and adjuvant therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and localization lung: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and lung chest: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung infiltrate: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and lung performance: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and lung thickening: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adjuvant therapy and lung chest: 1, 2
    • admission day and lung chest: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • admission day and lung infiltrate: 1, 2
    • admission day and lung performance: 1, 2, 3, 4, 5
    • localization lung and lung chest: 1, 2
    • localization lung and lung performance: 1